National AI Initiative for Precision Oncology (NAIPO)
Transforming cancer care with Artificial Intelligence



NAIPO is a new national initiative aims to develop a secure, Swiss-hosted infrastructure to enable AI-enhanced precision oncology across Switzerland while ensuring sensitive and personal health data remains protected.



Selected as a Flagship Initiative by Innosuisse, the Swiss Innovation Agency, NAIPO will unfold over four years under the leadership of the EPFL AI Center and ETH AI Center, uniting a large transdisciplinary team from a wide array of institutions including the Swiss Data Science Center (SDSC), the Swiss National Supercomputing Centre (CSCS), the Universities of Applied Sciences and Arts of Northwestern Switzerland, the Bern University of Applied Sciences, the Universities and University Hospitals of Basel, Bern, Geneva, and Zurich, Debiopharm, Roche, SOPHIA GENETICS, Switch, Tune Insight, as well as the regional hospitals of Aarau, Baden, Ticino, Luzern and Winterthur and the private clinics of Hirslanden and Swiss Medical Network.

This site is currently under construction.
Don't hesitate to come back very soon or contact us at info@naipo.ai.